1. Home
  2. COEP vs USIO Comparison

COEP vs USIO Comparison

Compare COEP & USIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • USIO
  • Stock Information
  • Founded
  • COEP 2017
  • USIO 1998
  • Country
  • COEP United States
  • USIO United States
  • Employees
  • COEP N/A
  • USIO N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • USIO Investment Bankers/Brokers/Service
  • Sector
  • COEP Health Care
  • USIO Finance
  • Exchange
  • COEP Nasdaq
  • USIO Nasdaq
  • Market Cap
  • COEP 32.0M
  • USIO 38.3M
  • IPO Year
  • COEP N/A
  • USIO N/A
  • Fundamental
  • Price
  • COEP $9.15
  • USIO $1.41
  • Analyst Decision
  • COEP
  • USIO Strong Buy
  • Analyst Count
  • COEP 0
  • USIO 2
  • Target Price
  • COEP N/A
  • USIO $5.00
  • AVG Volume (30 Days)
  • COEP 31.8K
  • USIO 69.9K
  • Earning Date
  • COEP 05-14-2025
  • USIO 05-14-2025
  • Dividend Yield
  • COEP N/A
  • USIO N/A
  • EPS Growth
  • COEP N/A
  • USIO N/A
  • EPS
  • COEP N/A
  • USIO 0.12
  • Revenue
  • COEP $62,874.00
  • USIO $83,970,504.00
  • Revenue This Year
  • COEP N/A
  • USIO $16.14
  • Revenue Next Year
  • COEP N/A
  • USIO $13.51
  • P/E Ratio
  • COEP N/A
  • USIO $11.79
  • Revenue Growth
  • COEP N/A
  • USIO 0.46
  • 52 Week Low
  • COEP $2.31
  • USIO $1.24
  • 52 Week High
  • COEP $13.70
  • USIO $2.92
  • Technical
  • Relative Strength Index (RSI)
  • COEP 46.80
  • USIO 40.97
  • Support Level
  • COEP $8.95
  • USIO $1.39
  • Resistance Level
  • COEP $9.85
  • USIO $1.49
  • Average True Range (ATR)
  • COEP 0.64
  • USIO 0.07
  • MACD
  • COEP -0.02
  • USIO -0.01
  • Stochastic Oscillator
  • COEP 10.47
  • USIO 18.18

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About USIO Usio Inc.

Usio Inc is a United States-based company that provides integrated electronic payment services, including credit and debit card-based processing services and transaction processing via the Automated Clearing House, or ACH network to billers and retailers. The Company also has an additional wholly-owned subsidiary, which is the entity for Output Solutions operations.

Share on Social Networks: